Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank86
Studio
Year-over-Year Change

Return on equity

Latest
-7.42%
↑ 72% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-26.22%
Historical baseline
PeriodValueYoY Change
2025-7.42%+81.0%
2024-38.97%+40.7%
2023-65.72%+31.2%
2022-95.51%-36.7%
2021-69.87%-16.4%
2020-60.01%-48.8%
2019-40.32%-124.0%
2018168.05%-